Home 禄 Business 禄 Manufacturing
Drug firm expects growth to double
By Ding Yining |
March 1, 2012, Thursday
|
Print Edition
Print Edition
BRISTOL-MYERS Squibb yesterday said it expects its China sales to grow by 27 percent this year, double the growth in 2011, based on strong demand for its key hepatitis and diabetes products.
Last year, its sales in China grew 13 percent annually, beating its global growth of 9 percent.
"We plan to introduce at least two new prescription drugs to the Chinese market this year and focus on getting more new innovative products registered in China," Jean-Christophe Pointeau, president of BMS China, said yesterday.
Last year, its sales in China grew 13 percent annually, beating its global growth of 9 percent.
"We plan to introduce at least two new prescription drugs to the Chinese market this year and focus on getting more new innovative products registered in China," Jean-Christophe Pointeau, president of BMS China, said yesterday.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
